Compare VIR & SCZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VIR | SCZM |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2019 | N/A |
| Metric | VIR | SCZM |
|---|---|---|
| Price | $9.03 | $12.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $29.30 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 515.5K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $68,556,000.00 | N/A |
| Revenue This Year | N/A | $22.30 |
| Revenue Next Year | $131.58 | $69.17 |
| P/E Ratio | ★ N/A | $14.27 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.16 | $8.92 |
| 52 Week High | $10.91 | $17.65 |
| Indicator | VIR | SCZM |
|---|---|---|
| Relative Strength Index (RSI) | 62.52 | 46.81 |
| Support Level | $4.88 | $10.50 |
| Resistance Level | N/A | $13.50 |
| Average True Range (ATR) | 0.58 | 0.78 |
| MACD | 0.16 | 0.37 |
| Stochastic Oscillator | 51.86 | 94.09 |
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
Santacruz Silver Mining Ltd is engaged in the operation, acquisition, exploration, and development of mineral properties in Latin America, with a primary focus on silver and zinc, including lead and copper. The company earns the majority of its revenue from Zinc and Silver. The company's reportable operating segments are the Bolivar mine and processing plant, the Porco mine and processing plant, the Caballo Blanco Group, San Lucas, Zimapan, and Corporate and Other activities. Key revenue is generated from Zimapan.